A sign for Eli Lilly and Co. sits outside their corporate headquarters in Indianapolis on April 26, 2017. A closely watched Alzheimer's drug from Eli Lilly won the backing of federal health advisers on Monday, setting the stage for the treatment's expected approval for people with mild dementia caused by the brain-robbing disease.
“Imposing a requirement for tau imaging is not necessary and would raise serious practical and access concerns to the treatment,” said Dr. Thomas Montine of Stanford University, who chaired the panel and summarized its opinion. In another key difference, Lilly studied taking patients off its drug when they reached very low levels of amyloid, a sticky brain plaque that's a contributor to Alzheimer's.
FDA's panel agreed that those the risks could be addressed by warning labels and education for doctors as well as medical scans to identify patients at greater risk of stroke.The Liberals support an effort to expand the scope of the foreign interference inquiry so it can investigate allegations against MPs, Democratic Institutions Minister Dominic LeBlanc said Monday.
Stellantis-owned Chrysler is recalling more than 211,000 SUVs and pickup trucks in the U.S., due to a software malfunction that could disable the cars' electronic stability control systems.Roots Corp. says it lost $8.9 million in its latest quarter as it missed out on some sales because it didn't have enough of its fleece products to keep up with demand and is still seeing shoppers grapple with economic headwinds.
Ottawa police say emergency crews received a 911 call just before 7 p.m. Sunday about a child, 'possibly drowning,' at the Carp River Conservation Area in Ottawa's west end.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: YahooFinanceCA - 🏆 47. / 63 Read more »
Source: BNNBloomberg - 🏆 83. / 50 Read more »
Source: BNNBloomberg - 🏆 83. / 50 Read more »